EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

The effect of Tocilizumab on the course and outcome of the disease in patients with COVID-19 pneumonia: Experience of a secondary-level hospital

Slađana Pavić, Radomir Slović, Aleksa Novković, Aleksandra Pavić

Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma · 2026 · 31 (101) · 88-109

DOI: 10.5937/mgiszm2601088p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma, 2026. Verfasst von Slađana Pavić und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The article does not contain abstract.

Zitieren

APA

Pavić, S., Slović, R., Novković, A., & Pavić, A. (2026). The effect of Tocilizumab on the course and outcome of the disease in patients with COVID-19 pneumonia: Experience of a secondary-level hospital. Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma, 31(101), 88-109. https://doi.org/10.5937/mgiszm2601088p

Vancouver

Pavić S, Slović R, Novković A, Pavić A. The effect of Tocilizumab on the course and outcome of the disease in patients with COVID-19 pneumonia: Experience of a secondary-level hospital. Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma. 2026;31(101):88-109. doi:10.5937/mgiszm2601088p

BibTeX
@article{Pavi2026,
  author = {Pavić, Slađana and Slović, Radomir and Novković, Aleksa and Pavić, Aleksandra},
  title = {The effect of Tocilizumab on the course and outcome of the disease in patients with COVID-19 pneumonia: Experience of a secondary-level hospital},
  journal = {Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma},
  year = {2026},
  volume = {31},
  number = {101},
  pages = {88--109},
  doi = {10.5937/mgiszm2601088p}
}
Kostenlos starten →